GTR 117737271
Tenders Are Invited For Pharmaceutical Products - New Medicinal Products Reimbursed From The Rare Disease Fund (11954)
ICB — International Competitive Bid
Closes Oct 21, 2026
Eastern Europe
Tender Information
GTR Reference
117737271
Tendering Authority
Subscribe to view
Tender No
605042-2026
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products - New Medicinal Products Reimbursed From The Rare Disease Fund (11954)
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Eastern Europe
Political Region
European Union
Last Date of Bid Submission
21-10-2026
Work Detail
Pharmaceutical Products - New Medicinal Products Reimbursed From The Rare Disease Fund (11954). 1. Belzutifan,2. Fampridines,3. Fenfluraminas,4. Levocarnitine,5. Levocarnitine,6. Sotaterceptas,7. Sotaterceptas,8. Legitimate*,9. Midostaurinas*,10. Pegunigalsidase Alfa*,11. Pegunigalsidase Alfa*
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
39b16779-bcce-4b30-bfd2-d1fabde71c55.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.